Dr. Mohideen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 W Central Rd
Arlington Heights, IL 60005Phone+1 847-618-6560Fax+1 847-618-6569
Education & Training
Loyola University Medical CenterResidency, Radiation Oncology, 1994 - 1997
ArMed Forces Medical College PuneClass of 1982
Certifications & Licensure
IL State Medical License 1993 - 2026- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 31 citationsRU486 increases radiosensitivity and restores apoptosis through modulation of HPV E6/E7 in dexamethasone-treated cervical carcinoma cells.Merideth C. Kamradt, Najeeb Mohideen, Andrew T M Vaughan
Gynecologic Oncology. 2000-04-01 - 26 citationsInhibition of radiation-induced apoptosis by dexamethasone in cervical carcinoma cell lines depends upon increased HPV E6/E7.M. C. Kamradt, Najeeb Mohideen, E. A. Krueger, Scott Walter, Andrew T M Vaughan
British Journal of Cancer. 2000-05-01 - 81 citationsMulticenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints.Robert M. Meier, Daniel A. Bloch, C. Cotrutz, Alan C. Beckman, G. Henning
International Journal of Radiation Oncology, Biology, Physics. 2018-10-01
Press Mentions
ACR 2021 in BriefMay 24th, 2021
How Has COVID-19 Impacted the Provision of Radiation Therapy?April 29th, 2020
ACR Members Appointed to MEDCACMarch 18th, 2016
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
